Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effects of Sirolimus on Anti-SARS-CoV-2 Vaccination in Patients With Lymphangioleiomyomatosis

CHEST Journal(2023)10.1016/j.chest.2023.09.014Source: DataRank Database

Effects of Sirolimus on Anti-SARS-CoV-2 Vaccination in Patients With Lymphangioleiomyomatosis is a research paper published in CHEST Journal (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.40)OA: greenTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Amanda Jones,Bennett Yang ORCID,Hiroko Ishiwata-Endo ORCID,Nishant Gupta ORCID,Joel Moss ORCID

Live enrichment

PubMed:37739031 PMC:PMC11026172 OpenAlex:https://openalex.org/W4386898785

National Heart, Lung, and Blood Institute

Grant: ZIA-HL-002541

Intramural NIH HHS

Grant: ZIA HL002541

National Heart Lung and Blood Institute Division of Intramural Research

National Institutes of Health

FWCI

2.40

Citation Percentile

0.9%

Citation Trend

2024

2025

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11026172/pdf/main.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0012369223055149?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0012369223055149?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11026172

Fields of Study

Tuberous Sclerosis Complex ResearchPolyomavirus and related diseasesInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

MeSH Terms

COVID-19Antibiotics, AntineoplasticHumansLungLung NeoplasmsLymphangioleiomyomatosisSirolimus

Keywords

LymphangioleiomyomatosisTuberous sclerosisMedicineSirolimusTSC2AngiomyolipomaLymphatic systemPI3K/AKT/mTOR pathwayLungTSC1Cancer researchLymphangiomatosisPathologyImmunologyInternal medicineSignal transductionKidneyGeneticsBiology

Sustainable Development Goals

SDG 0: Good health and well-being